Related Experiment Video
Updated: May 2, 2026
12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 10, 2011
22.2K
Clinical Telavancin Failure in Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia
Kevin T Dao1, Carlos D'Assumpcao2, Rupam Sharma1
1Internal Medicine, UCLA-Kern Medical, Bakersfield, USA.
Cureus
|March 28, 2025
Summary
Telavancin, a vancomycin-derived antibiotic, can fail to treat persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. This case study explores the reasons behind such treatment failure, offering insights into antibiotic resistance challenges.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Telavancin is a lipoglycopeptide antibiotic, a semi-synthetic derivative of vancomycin.
- It is primarily used to treat serious Gram-positive bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA).
- Despite its efficacy, antibiotic resistance and treatment failures can occur.
Observation:
- This article presents a clinical case of persistent MRSA bacteremia.
- The patient received telavancin treatment for the infection.
- Clinical failure of telavancin was observed during the treatment course.
Findings:
- The study details the specific circumstances leading to telavancin failure in this patient.
- Analysis of the failure mechanism is provided.
- Understanding the cause of failure is crucial for optimizing treatment strategies.
Implications:
- This case highlights the potential for telavancin treatment failure even in approved indications.
- It underscores the importance of monitoring treatment response and considering resistance mechanisms.
- Findings may inform future clinical practice guidelines and antibiotic development for MRSA infections.
Related Concept Videos
01:18Endocarditis III: Medical Management
360
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
360
01:28Antimicrobial Effectiveness
2.3K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.3K
01:30Development of Antibiotic Resistance
2.0K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
01:29Staphylococcal Skin Infections
143
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
143
01:25Mechanism of Antibiotic Resistance in MRSA
219
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
01:25Clinical Significance of Antibiotic Resistance
90
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90